S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.24 (+2.01%)
AMZN   1,767.38 (+1.78%)
CGC   20.10 (+6.57%)
NVDA   196.37 (+5.28%)
MU   46.46 (+3.54%)
BABA   175.29 (+2.41%)
GE   8.89 (+1.95%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
T   37.90 (+1.15%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
PRI   123.67 (+1.81%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
DIS   129.76 (+0.05%)
S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.24 (+2.01%)
AMZN   1,767.38 (+1.78%)
CGC   20.10 (+6.57%)
NVDA   196.37 (+5.28%)
MU   46.46 (+3.54%)
BABA   175.29 (+2.41%)
GE   8.89 (+1.95%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
T   37.90 (+1.15%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
PRI   123.67 (+1.81%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
DIS   129.76 (+0.05%)
Log in

Encompass Health Stock Price, News & Analysis (NYSE:EHC)

$64.71
+1.04 (+1.63 %)
(As of 10/15/2019 04:00 PM ET)
Today's Range
$63.81
Now: $64.71
$65.10
50-Day Range
$59.12
MA: $62.73
$65.62
52-Week Range
$56.74
Now: $64.71
$76.35
Volume468,475 shs
Average Volume760,544 shs
Market Capitalization$6.38 billion
P/E Ratio17.83
Dividend Yield1.76%
Beta0.84
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. Read More…

Industry, Sector and Symbol

Industry Hospitals
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone205-967-7116

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.28 billion
Cash Flow$5.77 per share
Book Value$15.74 per share

Profitability

Net Income$292.30 million

Miscellaneous

Employees30,060
Market Cap$6.38 billion
Next Earnings DateN/A
OptionableOptionable

Receive EHC News and Ratings via Email

Sign-up to receive the latest news and ratings for EHC and its competitors with MarketBeat's FREE daily newsletter.


Encompass Health (NYSE:EHC) Frequently Asked Questions

What is Encompass Health's stock symbol?

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health announced a quarterly dividend on Tuesday, July 23rd. Shareholders of record on Tuesday, October 1st will be paid a dividend of $0.28 per share on Tuesday, October 15th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.73%. The ex-dividend date of this dividend is Monday, September 30th. This is a positive change from Encompass Health's previous quarterly dividend of $0.27. View Encompass Health's Dividend History.

How were Encompass Health's earnings last quarter?

Encompass Health Corp (NYSE:EHC) posted its quarterly earnings data on Monday, July, 29th. The company reported $1.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.97 by $0.11. The firm had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.13 billion. Encompass Health had a return on equity of 24.10% and a net margin of 7.01%. View Encompass Health's Earnings History.

What price target have analysts set for EHC?

7 equities research analysts have issued 12 month target prices for Encompass Health's shares. Their forecasts range from $70.00 to $86.00. On average, they anticipate Encompass Health's share price to reach $74.60 in the next twelve months. This suggests a possible upside of 15.3% from the stock's current price. View Analyst Price Targets for Encompass Health.

What is the consensus analysts' recommendation for Encompass Health?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last year. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Encompass Health.

Has Encompass Health been receiving favorable news coverage?

News stories about EHC stock have been trending neutral this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Encompass Health earned a coverage optimism score of 0.4 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Encompass Health.

Who are some of Encompass Health's key competitors?

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include Edwards Lifesciences (EW), salesforce.com (CRM), Axon Enterprise (AAXN), Illumina (ILMN), Mongodb (MDB), Paypal (PYPL), Adobe (ADBE), Proofpoint (PFPT), Brookfield Infrastructure Partners (BIP) and Johnson & Johnson (JNJ).

Who are Encompass Health's key executives?

Encompass Health's management team includes the folowing people:
  • Mr. Mark J. Tarr, CEO, Pres & Director (Age 57)
  • Mr. Douglas E. Coltharp, Exec. VP & CFO (Age 57)
  • Mr. John Patrick Darby, Exec. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Ms. Barbara Ann Jacobsmeyer, Exec. VP & Pres Inpatient Hospitals (Age 53)
  • Mr. Andrew L. Price, Sr. VP & Chief Accounting Officer (Age 52)

How do I buy shares of Encompass Health?

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Encompass Health's stock price today?

One share of EHC stock can currently be purchased for approximately $64.71.

How big of a company is Encompass Health?

Encompass Health has a market capitalization of $6.38 billion and generates $4.28 billion in revenue each year. The company earns $292.30 million in net income (profit) each year or $3.63 on an earnings per share basis. Encompass Health employs 30,060 workers across the globe.View Additional Information About Encompass Health.

What is Encompass Health's official website?

The official website for Encompass Health is http://www.encompasshealth.com/.

How can I contact Encompass Health?

Encompass Health's mailing address is 9001 LIBERTY PARKWAY, BIRMINGHAM AL, 35242. The company can be reached via phone at 205-967-7116 or via email at [email protected]


MarketBeat Community Rating for Encompass Health (NYSE EHC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  134 (Vote Outperform)
Underperform Votes:  119 (Vote Underperform)
Total Votes:  253
MarketBeat's community ratings are surveys of what our community members think about Encompass Health and other stocks. Vote "Outperform" if you believe EHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Featured Article: Institutional Investors

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel